Formulation

Jun 15, 2016
BioPharm International
By BioPharm International Editors
Technology advances enable contract service providers to keep pace with the demands of existing and emerging biologic-based therapies.
May 19, 2016
A new study in Nature Communications explores how to remove the bulk of the soaps that are added to injectables to make hydrophobic drugs more soluble.
May 18, 2016
The company’s method reduces the time required to crystallize antibodies from weeks to one day.
Apr 01, 2016
BioPharm International
Headspace moisture analysis is a rapid non-destructive analytical method that may potentially address the limitations of traditional methods used for residual moisture determination.
Apr 01, 2016
BioPharm International
Demand is driving expansion and consolidation of formulation and clinical trial materials services.
Apr 01, 2016
BioPharm International
Collaboration and single-use technologies aided the rapid scale-up of Ebola vaccine manufacturing
Mar 02, 2016
BioPharm International
The US DEA will allow Kannalife access to pharmaceutical-grade cannabidiol to conduct feasibility studies for a potential treatment for neurodegenerative diseases.
Feb 01, 2016
BioPharm International
The use of orthogonal methods to SEC is discussed; examples show how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.
Dec 04, 2015
The company plans to reformulate injectable products to make them into inhaled and intranasal medications.
Nov 30, 2015
By BioPharm International Editors
Paras Biopharmaceuticals and Novozymes will collaborate on the creation of an improved osteoporosis treatment.
native1_300x100
lorem ipsum